Literature DB >> 21105113

Teaching new tricks to an old foe: murinizing hepatitis C virus.

Gisa Gerold1, Charles M Rice, Alexander Ploss.   

Abstract

Entities:  

Year:  2010        PMID: 21105113      PMCID: PMC4509484          DOI: 10.1002/hep.24045

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  15 in total

1.  Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.

Authors:  Karl-Dimiter Bissig; Stefan F Wieland; Phu Tran; Masanori Isogawa; Tam T Le; Francis V Chisari; Inder M Verma
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122.

Authors:  Liang-Tzung Lin; Ryan S Noyce; Tram N Q Pham; Joyce A Wilson; Gary R Sisson; Thomas I Michalak; Karen L Mossman; Christopher D Richardson
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus.

Authors:  M Dandri; M R Burda; E Török; J M Pollok; A Iwanska; G Sommer; X Rogiers; C E Rogler; S Gupta; H Will; H Greten; J Petersen
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

4.  Binding of hepatitis C virus to CD81.

Authors:  P Pileri; Y Uematsu; S Campagnoli; G Galli; F Falugi; R Petracca; A J Weiner; M Houghton; D Rosa; G Grandi; S Abrignani
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

Review 5.  The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.

Authors:  Philip Meuleman; Geert Leroux-Roels
Journal:  Antiviral Res       Date:  2008-08-14       Impact factor: 5.970

6.  Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge.

Authors:  Mansun Law; Toshiaki Maruyama; Jamie Lewis; Erick Giang; Alexander W Tarr; Zania Stamataki; Pablo Gastaminza; Francis V Chisari; Ian M Jones; Robert I Fox; Jonathan K Ball; Jane A McKeating; Norman M Kneteman; Dennis R Burton
Journal:  Nat Med       Date:  2007-12-06       Impact factor: 53.440

7.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

8.  Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry.

Authors:  Donna M Tscherne; Christopher T Jones; Matthew J Evans; Brett D Lindenbach; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 9.  Towards a small animal model for hepatitis C.

Authors:  Alexander Ploss; Charles M Rice
Journal:  EMBO Rep       Date:  2009-10-16       Impact factor: 8.807

10.  Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Authors:  Alexander Ploss; Matthew J Evans; Valeriya A Gaysinskaya; Maryline Panis; Hana You; Ype P de Jong; Charles M Rice
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.